Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:13 pm Unchanged | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | AMERICAN INTERNATIONAL GROUP INC. AIG | 2,517,173 8.500% | 0 (Unchanged) | View |
| 2024-02-09 5:10 pm Sale | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | Artal International S.C.A. | 1,141,309 3.900% | -465,000 (-28.95%) | View |
| 2023-02-14 2:25 pm Sale | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | 683 Capital Management LLC | 1,330,889 4.500% | -521,246 (-28.14%) | View |
| 2023-02-14 07:55 am Sale | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | AMERICAN INTERNATIONAL GROUP INC. AIG | 2,517,173 8.500% | -12,099 (-0.48%) | View |
| 2023-02-14 06:13 am Unchanged | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | NanoDimension II Management Ltd | 1,445,221 4.900% | 0 (Unchanged) | View |
| 2023-02-10 7:53 pm Purchase | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | Artal International S.C.A. | 1,606,309 5.500% | 1,606,309 (New Position) | View |
| 2022-02-14 3:51 pm Purchase | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | AMERICAN INTERNATIONAL GROUP INC. AIG | 2,529,272 9.000% | 281,306 (+12.51%) | View |
| 2022-02-14 06:32 am Purchase | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | Temasek Holdings (Private) Ltd | 2,758,169 9.800% | 244,245 (+9.72%) | View |
| 2022-02-11 6:47 pm Purchase | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | 683 Capital Management LLC | 1,852,135 6.600% | 274,049 (+17.37%) | View |
| 2022-02-11 5:12 pm Purchase | 13D | SQZ BIOTECHNOLOGIES CO COM SQZB | Polaris Management Co. VII L.L.C. | 3,226,914 11.400% | 16,051 (+0.50%) | View |
| 2022-02-10 4:08 pm Sale | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | NanoDimension II Management Ltd | 1,445,221 5.100% | -38,749 (-2.61%) | View |
| 2022-02-09 5:22 pm Sale | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | BlackRock Inc. BLK | 1,401,995 4.990% | -11,875 (-0.84%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | BlackRock Inc. BLK | 1,413,870 5.000% | 1,413,870 (New Position) | View |
| 2021-08-09 4:59 pm Purchase | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | 683 Capital Management LLC | 1,578,086 5.600% | 1,578,086 (New Position) | View |
| 2021-02-18 5:36 pm Purchase | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | NanoDimension II Management Ltd | 1,483,970 6.000% | 1,483,970 (New Position) | View |
| 2021-02-16 3:19 pm Purchase | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | AMERICAN INTERNATIONAL GROUP INC. AIG | 2,247,966 9.100% | 2,247,966 (New Position) | View |
| 2021-02-12 9:20 pm Unchanged | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | Invus Public Equities L.P. | 1,606,308 6.500% | 0 (Unchanged) | View |
| 2020-11-13 5:03 pm Purchase | 13D | SQZ BIOTECHNOLOGIES CO COM SQZB | Polaris Management Co. VII L.L.C. | 3,210,863 13.400% | 3,210,863 (New Position) | View |
| 2020-11-13 4:54 pm Purchase | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | Temasek Holdings (Private) Ltd | 2,513,924 10.500% | 2,513,924 (New Position) | View |
| 2020-11-13 4:51 pm Purchase | 13G | SQZ BIOTECHNOLOGIES CO COM SQZB | Invus Public Equities L.P. | 1,606,308 6.500% | 1,606,308 (New Position) | View |